Bacil Pharma — 360° view

Bacil Pharma (BSE: BACPHAR) closed at ₹16.08 on 20 Nov 2026, with a market value of ₹23 crore.

Bacil Pharma (BSE: BACPHAR) closed at ₹16.08 on 20 Nov 2026, down 55.4% over the past year. Its market capitalisation is ₹23 crore and it trades at 14.8 times earnings.

Share price
₹16.08 (20 Nov 2026)
Market cap
₹23 Cr (20 Nov 2026)
P/E
14.80 (20 Nov 2026)
ROCE
3.93% (FY26)
ROE
6.21% (FY26)
Book value
₹17.6 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹61.80 / ₹10.65 (20 Nov 2026)
1-year return
-55.4% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: BACPHAR

Bacil Pharma Limited is a Mumbai-registered listed company incorporated in 1987. Although its stated business is pharmaceutical healthcare, it recorded no core operating revenue in FY26 and is currently an investment/other-income-led, non-operating company evaluating future business opportunities.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.